Manufacturing defect leads to temporary halt of rabies vaccine production

04/29/2010 |

Merial recently announced that it has temporarily stopped releasing IMRAB rabies vaccines, after discovering a defect in a small number of vials. The problem doesn't affect doses on the market, a spokeswoman said. "Merial is working cooperatively with the USDA to remedy the issues and return to full supply as soon as possible," the Duluth, Ga., company said.

View Full Article in:

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Associate Director, Promotion Integrity
Bristol-Myers Squibb
Plainsboro, NJ
Vice President, Medicare Advantage
Baton Rouge, LA
Director, Global Integrity and Compliance, Pharmaceuticals
Fort Worth, TX